Cytokine removal in extracorporeal blood purification: an in vitro study S Harm, C Schildböck, J Hartmann Blood Purification 49 (1-2), 33-43, 2020 | 66 | 2020 |
Pore size–a key property for selective toxin removal in blood purification S Harm, D Falkenhagen, J Hartmann The International journal of artificial organs 37 (9), 668-678, 2014 | 57 | 2014 |
Ex vivo investigation on internal tunnel approach/internal resin infiltration and external nanosilver-modified resin infiltration of proximal caries exceeding into dentin AM Kielbassa, MR Leimer, J Hartmann, S Harm, M Pasztorek, IB Ulrich PLoS One 15 (1), e0228249, 2020 | 41 | 2020 |
Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations? S Harm, D Falkenhagen, J Hartmann The International journal of artificial organs 37 (3), 222-232, 2014 | 38 | 2014 |
Effective removal of estrogens from drinking water and wastewater by adsorption technology J Hartmann, R Beyer, S Harm Environmental Processes 1, 87-94, 2014 | 37 | 2014 |
Sorbent for endotoxins D Falkenhagen, S Harm, J Hartmann, V Weber US Patent 9,440,019, 2016 | 24* | 2016 |
An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test S Harm, C Schildböck, K Strobl, J Hartmann Scientific Reports 11 (1), 4192, 2021 | 23 | 2021 |
Low-dose polymyxin: an option for therapy of Gram-negative sepsis S Harm, F Gabor, J Hartmann Innate immunity 22 (4), 274-283, 2016 | 23 | 2016 |
The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters K Strobl, S Harm, V Weber, J Hartmann The International journal of artificial organs 40 (1), 15-21, 2017 | 21 | 2017 |
Blood compatibility—an important but often forgotten aspect of the characterization of antimicrobial peptides for clinical application S Harm, K Lohner, U Fichtinger, C Schildböck, J Zottl, J Hartmann International Journal of Molecular Sciences 20 (21), 5426, 2019 | 15 | 2019 |
Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification S Harm, C Schildböck, J Hartmann PLoS One 13 (1), e0191741, 2018 | 14 | 2018 |
Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device-the hybrid-MDS S Harm, K Strobl, J Hartmann, D Falkenhagen The International Journal of Artificial Organs 32 (11), 769-778, 2009 | 14 | 2009 |
Clearance of selected plasma cytokines with continuous veno-venous hemodialysis using ultraflux EMiC2 versus ultraflux AV1000S T Eichhorn, J Hartmann, S Harm, I Linsberger, F König, G Valicek, ... Blood purification 44 (4), 260-266, 2017 | 13 | 2017 |
Characterization of adsorbents for cytokine removal from blood in an in vitro model S Harm, F Gabor, J Hartmann Journal of Immunology Research 2015, 2015 | 13 | 2015 |
Removal of bile acids by extracorporeal therapies: an in vitro study J Hartmann, S Harm The International Journal of Artificial Organs 41 (1), 52-57, 2018 | 11 | 2018 |
ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016 T Velasquez, G Mackey, J Lusk, UG Kyle, T Fontenot, P Marshall, ... Intensive Care Medicine Experimental 4, 405-607, 2016 | 9 | 2016 |
Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup J Gubensek, K Strobl, S Harm, R Weiss, T Eichhorn, J Buturovic-Ponikvar, ... PLoS One 13 (6), e0199204, 2018 | 8 | 2018 |
Adsorption of the inflammatory mediator high-mobility group box 1 by polymers with different charge and porosity C Tripisciano, T Eichhorn, S Harm, V Weber BioMed Research International 2014, 2014 | 7 | 2014 |
Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR M Pilecky, S Harm, C Bauer, J Zottl, R Emprechtinger, T Eichhorn, ... Journal of Infection 84 (4), 579-613, 2022 | 6 | 2022 |
A new integrated technique for the supportive treatment of sepsis J Hartmann, S Harm The International Journal of Artificial Organs 40 (1), 4-8, 2017 | 6 | 2017 |